Adult healthy transgender men Endothelial function Flow mediated dilatation Testosterone Transgender men
Conditions
Interventions
Sponsors
Ratchadapisek Research Funds
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women age 20-40 years who desire to be transgender male have not received GAHT and performed gender reassignment surgery
Exclusion criteria
Exclusion criteria: Having history of clinical atherosclerosis, metabolic disease, hypertension, gynecologic disease Smoking Using cardiovascular medication or medication that would affect vasoconstriction or vasodilation or testosterone metabolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| flow mediated dilatation (FMD) day 0 and 3 months brachial artery ultrasound | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of lipid profile and Hb/Hct between pre and posttreatment with supraphysiologic testosterone therapy among transgender male day 0 and 3 months blood test | — |
Countries
Thailand
Contacts
Public ContactNutthida Mahakij
Chulalongkorn university
Outcome results
None listed